DIAGNOS (CVE:ADK) Director Purchases 200,000 Shares

DIAGNOS Inc. (CVE:ADK) Director Robert Dunn purchased 200,000 shares of the firm’s stock in a transaction dated Wednesday, July 29th. The shares were bought at an average price of C$0.30 per share, with a total value of C$60,000.00. Following the purchase, the director owned 2,117,778 shares in the company, valued at C$635,333.40. This represents a 10.43% increase in their position.

DIAGNOS Stock Performance

Shares of ADK stock traded up C$0.01 during trading on Friday, reaching C$0.28. The company had a trading volume of 35,149 shares, compared to its average volume of 210,613. The firm’s 50 day simple moving average is C$0.23 and its two-hundred day simple moving average is C$0.26. DIAGNOS Inc. has a one year low of C$0.17 and a one year high of C$0.41. The company has a debt-to-equity ratio of 204.05, a current ratio of 1.49 and a quick ratio of 0.68. The company has a market capitalization of C$33.72 million, a PE ratio of -7.00 and a beta of -0.12.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.